Hanseatic Management Services’s Array Biopharma Inc ARRY Stock Holding History

Hanseatic Management Services’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,553	Closed	-$282K	–	292
2019 Q1	$282K	Buy	11,553 +105	+0.9%	+$2.19K	0.29%	96
2018 Q4	$163K	Buy	11,448 +1	+0%	+$15	0.22%	103
2018 Q3	$174K	Sell	11,447 -12,767	-53%	-$196K	0.16%	125
2018 Q2	$406K	Buy	24,214 +10,978	+83%	+$175K	0.35%	104
2018 Q1	$216K	Buy	13,236 +13,164	+18,283%	+$211K	0.21%	120
2017 Q4	$1K	Buy	+72	New	+$819	﹤0.01%	423
2017 Q2	–	Sell	-142	Closed	-$1K	–	488
2017 Q1	$1K	Hold	142	–	–	﹤0.01%	385
2016 Q4	$1K	Buy	+142	New	+$1.04K	﹤0.01%	304
2013 Q3	–	Sell	-4,837	Closed	-$22K	–	289
2013 Q2	$22K	Buy	+4,837	New	+$26K	0.01%	159

Other funds holding ARRY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Hanseatic Management Services's ARRY Position: Q2 2019 in Review

Hanseatic Management Services sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 11,553 shares — an estimated $282K sold.

Hanseatic Management Services first reported a position in ARRY in Q2 2013 and held it in 9 quarters. The position peaked at $406K in Q2 2018. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

Hanseatic Management Services reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
Hanseatic Management Services sold 11,553 Array Biopharma Inc shares in Q2 2019, an estimated $282K.
Hanseatic Management Services first reported a position in Array Biopharma Inc in Q2 2013 and held it in 9 quarters.
Hanseatic Management Services's Array Biopharma Inc position peaked at $406K in Q2 2018.
318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Hanseatic Management Services's 13F filing for Q2 2019, filed 19 Jul 2019.